Illinois Appellate Court Affirms $45 Million Mesothelioma Verdict Against Johnson & Johnson and Kenvue

Regulation
โดย Business Wire·Read original
Summary · why it matters

The Illinois Appellate Court has affirmed a $45 million jury verdict awarded to the family of Theresa Garcia, who died of mesothelioma after decades of using Johnson & Johnson's Baby Powder. The court rejected Johnson & Johnson's efforts to overturn the verdict or reduce the judgment, upholding the trial court's denial of the company's requests for judgment notwithstanding the verdict, a new trial, and its challenge to Illinois' prejudgment interest statute. The appellate court also upheld findings that Kenvue Inc. and Johnson & Johnson Holdco (NA), Inc. could be held liable as successors to Johnson & Johnson's former consumer products business despite corporate restructuring, and affirmed the jury's award for years of life lost under the Illinois Survival Act. The decision marks a significant appellate victory for asbestos victims and contradicts Johnson & Johnson's public assertions that adverse talc verdicts rarely survive appellate review.

Impact on stocks 2

Biotech & Genomic Medicine▼ · 1 stocks
Johnson & Johnson
JNJ
▼ NegativeRegulationrelevance

Appellate court affirmed $45M mesothelioma verdict against J&J, rejecting its appeals and upholding liability.

Consumer Staples▼ · 1 stocks
Kenvue Inc.
KVUE
▼ NegativeRegulationrelevance

Kenvue held liable as successor in the same talc verdict, affirming its responsibility despite corporate restructuring.

Off-coverage companies 1

Johnson & Johnson Holdco (NA), Inc.Private▼ Negative
Regulationrelevance

Johnson & Johnson Holdco (NA) also held liable as successor in the affirmed $45M verdict.

© 2026 MarketDXNews